Workflow
Medicines and therapies in Immunology
icon
搜索文档
Evercore ISI Tweaks AbbVie (ABBV) Estimates, Lowers Price Target Marginally
Yahoo Finance· 2026-04-16 01:10
AbbVie Inc. (NYSE:ABBV) is included among the Early Retirement Portfolio: Top 15 Stocks to Buy. On April 13, Evercore ISI lowered its price recommendation on AbbVie Inc. (NYSE:ABBV) to $232 from $233. It reiterated an Outperform rating on the shares. The adjustment came as the analyst updated estimates in a Q1 preview note. A few days earlier, on April 6, AbbVie issued a preliminary financial update, lowering its earnings expectations for both the first quarter and the full year of 2026. The revision was dr ...